Related Experiment Video
Updated: Jul 14, 2026

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
METTL14/m6A/CEBPD axis: A critical player in chronic cerebral hypoperfusion-associated neuroinflammation
Huanhuan Wang1, Hanshu Zhao1, Jiadi Gao1
1Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, PR China.
Abstract:
Vascular dementia (VaD) is a major cause of cognitive decline in the elderly, with chronic cerebral hypoperfusion (CCH) as its core pathogeny linked to neuroinflammation. Microglial M1 polarization drives CCH-related neuroinflammation, but its epigenetic regulation remains unclear. N6-methyladenosine (m6A) modification, centered on methyltransferase-like 14 (METTL14), is abundant in the brain, while CCAAT enhancer binding protein delta (CEBPD) is associated with central nervous system inflammation. This study explored METTL14's role in microglial polarization and CCH pathology. In vitro, HMC3 cells induced by LPS/TNF-α (10 μg/mL, 50 ng/mL) showed upregulated METTL14 and CEBPD. METTL14 knockdown via short hairpin RNA inhibited the expression of M1 phenotypic markers (iNOS, CD86), reduced the release of pro-inflammatory factors (IL-1β, IL-6), and blocked NF-κB nuclear translocation, indicating that METTL14 silencing suppresses LPS/TNF-α-induced microglial M1 polarization and inflammatory response. In bilateral common carotid artery occlusion (BCCAo)-induced CCH rats, hippocampal METTL14/CEBPD was elevated. Adeno-associated virus-mediated METTL14 knockdown not only attenuated neuroinflammation and neuronal apoptosis in hippocampal CA1, but also significantly improved spatial learning memory and object recognition ability. Mechanistically, RIP-PCR and MeRIP-qPCR confirmed METTL14 enhances CEBPD mRNA stability via m6A modification. CEBPD overexpression reversed METTL14 knockdown's effect, identifying it as a key downstream mediator. In conclusion, METTL14 knockdown impairs CEBPD mRNA stability via m6A, inhibits TLR4/MyD88/NF-κB pathway and microglial M1 polarization, alleviating CCH-related neuroinflammation and cognitive impairment, providing a potential epigenetic target for VaD.
Insights
Targeting METTL14 reduces neuroinflammation and cognitive decline in vascular dementia. This epigenetic approach suppresses microglial M1 polarization by stabilizing CEBPD mRNA, offering a potential therapy for this condition.
Area of Science:
- Neuroscience
- Epigenetics
- Molecular Biology
Background:
- Vascular dementia (VaD) involves cognitive decline due to chronic cerebral hypoperfusion (CCH) and neuroinflammation.
- Microglial M1 polarization is a key driver of CCH-related neuroinflammation, but its epigenetic regulation is not fully understood.
- N6-methyladenosine (m6A) modification, particularly involving METTL14, and CCAAT enhancer binding protein delta (CEBPD) are implicated in brain inflammation.
Purpose of the Study:
- To investigate the role of METTL14 in microglial polarization and its impact on chronic cerebral hypoperfusion (CCH) pathology.
- To elucidate the epigenetic mechanism by which METTL14 influences neuroinflammation and cognitive function in vascular dementia (VaD).
Main Methods:
- In vitro studies using HMC3 cells treated with LPS/TNF-α to assess METTL14 and CEBPD expression and microglial polarization.
- In vivo studies using bilateral common carotid artery occlusion (BCCAo)-induced CCH rat models.
- Short hairpin RNA (shRNA) and adeno-associated virus (AAV) mediated knockdown of METTL14.
- RNA immunoprecipitation-PCR (RIP-PCR) and m6A-specific immunoprecipitation-PCR (MeRIP-qPCR) to confirm m6A modification and mRNA stability.
- Assessment of cognitive function using spatial learning and memory and object recognition tests.
Main Results:
- METTL14 knockdown suppressed LPS/TNF-α-induced M1 polarization in HMC3 cells, reducing pro-inflammatory factors and NF-κB activation.
- In CCH rats, hippocampal METTL14 and CEBPD levels were elevated.
- AAV-mediated METTL14 knockdown in CCH rats attenuated neuroinflammation, neuronal apoptosis, and improved cognitive deficits.
- METTL14 was confirmed to enhance CEBPD mRNA stability through m6A modification, with CEBPD acting as a downstream mediator.
Conclusions:
- METTL14 knockdown inhibits microglial M1 polarization and neuroinflammation in CCH by impairing CEBPD mRNA stability via m6A modification.
- This process involves the TLR4/MyD88/NF-κB pathway, leading to alleviation of cognitive impairment in vascular dementia.
- METTL14 represents a potential epigenetic therapeutic target for vascular dementia.
More Related Videos
07:21Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
08:27Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Cerebral Edema ll: Pathophysiology